{"id":26330,"date":"2020-07-06T05:46:01","date_gmt":"2020-07-06T05:46:01","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=26330"},"modified":"2020-09-30T10:42:34","modified_gmt":"2020-09-30T10:42:34","slug":"catie-clinical-antipsychotic-trials-of-intervention-effectiveness","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/","title":{"rendered":"Catie (Clinical antipsychotic trials of intervention effectiveness)"},"content":{"rendered":"

A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).<\/p>\n

\n

The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.<\/p>\n

\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-26330","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"\nCatie (Clinical antipsychotic trials of intervention effectiveness) - Definition of Catie (Clinical antipsychotic trials of intervention effectiveness)<\/title>\n<meta name=\"description\" content=\"A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Catie (Clinical antipsychotic trials of intervention effectiveness) - Definition of Catie (Clinical antipsychotic trials of intervention effectiveness)\" \/>\n<meta property=\"og:description\" content=\"A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-06T05:46:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-09-30T10:42:34+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/\",\"name\":\"Catie (Clinical antipsychotic trials of intervention effectiveness) - Definition of Catie (Clinical antipsychotic trials of intervention effectiveness)\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-07-06T05:46:01+00:00\",\"dateModified\":\"2020-09-30T10:42:34+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Catie (Clinical antipsychotic trials of intervention effectiveness)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Catie (Clinical antipsychotic trials of intervention effectiveness) - Definition of Catie (Clinical antipsychotic trials of intervention effectiveness)","description":"A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/","og_locale":"en_US","og_type":"article","og_title":"Catie (Clinical antipsychotic trials of intervention effectiveness) - Definition of Catie (Clinical antipsychotic trials of intervention effectiveness)","og_description":"A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/","og_site_name":"Glossary","article_published_time":"2020-07-06T05:46:01+00:00","article_modified_time":"2020-09-30T10:42:34+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/","name":"Catie (Clinical antipsychotic trials of intervention effectiveness) - Definition of Catie (Clinical antipsychotic trials of intervention effectiveness)","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-07-06T05:46:01+00:00","dateModified":"2020-09-30T10:42:34+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A nationwide public health\u2013focused clinical trial that compared the effectiveness of \u201cfirst generation\u201d (introduced in the 1950s) and \u201csecond generation\u201d (available since the 1990s) antipsychotic medications. Phase i of catie analyzed the economic implications of antipsychotic treatment and concluded that the older conventional antipsychotic perphenazine was less expensive and no less effective than the newer atypical antipsychotics olanzapine, quetiapine, risperidone, and ziprasidone during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia. The study was funded by the national institute of mental health (NIMH).The development of new drugs consists of 4 phases: 1. preclinical studies, 2. clinical studies phase I, 3. clinical studies phase II and 4. clinical studies phase III.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/catie-clinical-antipsychotic-trials-of-intervention-effectiveness\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Catie (Clinical antipsychotic trials of intervention effectiveness)"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/26330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=26330"}],"version-history":[{"count":3,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/26330\/revisions"}],"predecessor-version":[{"id":45942,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/26330\/revisions\/45942"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=26330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=26330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=26330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}